The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...

Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates.  | The administration's second stab ...

New platform unifies data, automates workflows, and delivers predictive intelligence to help pharmacists and other health care providers maximize 340B performance, improve and accelerate patient ...

In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...

A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency ...

The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...

AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.

The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April ...

LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered ...

While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.

Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from limiting access.